Anterix Inc. (ATEX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Sales | 6,031 | 4,191 | 1,919 | 1,084 | 921 |
| Cost of Goods | N/A | N/A | N/A | 5 | 1,606 |
| Gross Profit | 6,031 | 4,191 | 1,919 | 1,079 | -685 |
| Operating Expenses | 17,745 | 14,313 | 18,380 | 37,932 | 54,730 |
| Operating Income | -11,714 | -10,122 | -16,461 | -36,848 | -54,809 |
| Other Income | 2,234 | 2,607 | 1,406 | 312 | 499 |
| Pre-tax Income | -9,480 | -7,515 | -15,055 | -36,536 | -54,310 |
| Income Tax | 1,892 | 1,613 | 1,262 | 983 | 124 |
| Net Income Continuous | -11,372 | -9,128 | -16,317 | -37,519 | -54,434 |
| Net Income | $-11,372 | $-9,128 | $-16,317 | $-37,519 | $-54,434 |
| EPS Basic Total Ops | -0.61 | -0.49 | -0.87 | -2.07 | -3.13 |
| EPS Basic Continuous Ops | -0.61 | -0.49 | -0.87 | -2.07 | -3.13 |
| EPS Diluted Total Ops | -0.61 | -0.49 | -0.87 | -2.07 | -3.13 |
| EPS Diluted Continuous Ops | -0.61 | -0.49 | -0.87 | -2.07 | -3.13 |
| EPS Diluted Before Non-Recurring Items | -2.36 | -0.49 | -2.33 | -2.07 | -3.13 |
| EBITDA(a) | $-11,166 | $-9,278 | $-15,041 | $-35,398 | $-51,276 |